Faiza Gauba, | |
500 Laser Rd Ne, Rio Rancho, NM 87124-4517 | |
(505) 962-1242 | |
Not Available |
Full Name | Faiza Gauba |
---|---|
Gender | Female |
Speciality | Speech-language Pathologist |
Location | 500 Laser Rd Ne, Rio Rancho, New Mexico |
Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1033994959 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
235Z00000X | Speech-language Pathologist | SLPCF23043 (New Mexico) | Primary |
Mailing Address | Practice Location Address |
---|---|
Faiza Gauba, 500 Laser Rd Ne, Rio Rancho, NM 87124-4517 Ph: (505) 962-1242 | Faiza Gauba, 500 Laser Rd Ne, Rio Rancho, NM 87124-4517 Ph: (505) 962-1242 |
News Archive
Black gay couples tend to practice safe sex but don't talk about it, while white gay couples discuss safety but are less likely to use condoms, according to new findings presented at the 19th International AIDS Conference.
Rib-X Pharmaceuticals, Inc., a development-stage antibiotics company with a broad product pipeline based on its innovative discovery platform, and Yale University today announced the discovery by Thomas Steitz, Ph.D., co-founder of Rib-X and Yale University professor, of important new ribosomal structures of antibiotics, enabling the potential creation of novel treatments for drug resistant infections, including resistant tuberculosis (TB).
The roots of cassava (Manihot esculenta) serve as the primary source of carbohydrates in the diets of people in many arid regions of the world, including more than 250 million people in sub-Saharan Africa. Unfortunately the roots of commercial cassava cultivars are quite low in micronutrients, and micronutrient deficiencies are widespread in these regions.
A network established by staff at the University of Plymouth has launched a new platform to push forward with worldwide antibiotic research and discovery.
Verastem, Inc., focused on discovering and developing drugs to treat cancer by the targeted killing of cancer stem cells, announced positive results from the Phase 1 portion of its Phase 1/1b study of defactinib (VS-6063) in combination with paclitaxel in patients with ovarian cancer that were presented at the 2013 AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics in Boston.
› Verified 2 days ago
Shannon Carryn Troutman, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 500 Laser Rd Ne, Rio Rancho, NM 87124 Phone: 505-771-2366 | |
Alexis K Medina, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 500 Laser Rd Ne, Rio Rancho, NM 87124 Phone: 505-962-1242 | |
Jeannette L. Waters, M.S., CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 2148 Sagecrest Loop Ne, Rio Rancho, NM 87144 Phone: 505-463-8195 | |
Cynthia Reynoso, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 500 Laser Rd Ne, Rio Rancho, NM 87124 Phone: 505-962-1242 | |
Desert Rose Speech Therapy Llc Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 3091 Ashkirk Loop Se, Rio Rancho, NM 87124 Phone: 505-306-8100 | |
Jessica M De Sanctis, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 500 Laser Rd Ne, Rio Rancho, NM 87124 Phone: 505-962-1242 |